INTRODUCTION
Poison oak, poison ivy, and poison sumac plants are members of the family Anacardiaceae. These plants produce an oil which can cause contact sensitivity in humans and animals. The dermatitis is minimal upon the initial sensitizing exposure, but subsequent exposures result in erythematous-indurated suppurating lesions at the site of application appearing 24-48 h later (1) . Approximately 80% of the United States population is immune to poison oak or ivy because of prior exposure, and 50% are clinically reactive (2) . The debilitating dermatitis resulting from contact with the Received for publication 7 February 1979 and in revised form 11 June 1979. plant represents a severe hazard for outdoor workers (3, 4) . For this reason there is a great interest in developing a method of tolerizing such "at risk" individuals against poison oak, ivy, and sumac.
The oils extracted from all three plants are closely related chemically and are called urushiols. They are composed ofmixtures of3-n-alk(en)ylcatechols (Fig. 1) in which the side chains consist of either a C-15 or a C-17 moiety. The saturated and the mono-, di-, and triene forms are present. Whereas urushiol derived from poison ivy is composed predominantly of compounds with C-15 side chains (5) , poison oak urushiol contains more of the compounds with C-17 side chains (6, 7) . The di-and tri-olefins are the major components of both urushiols, and the two oils are highly cross reactive (8) . In vivo studies in humans sensitized by accidental exposure have shown that the dienes and the trienes are far more antigenic than the saturated components of the urushiol mixture, 3-n-pentadecycatechol (PDC)' and 3-n-heptadecylcatechol (HDC), which are about one-tenth as active as the corresponding dienes (9) .
An in vitro blastogenesis assay for cellular immunity to poison oak using human peripheral blood lymphocytes was developed to define the nature of the reaction, the specificity of the antigen receptors, and, eventually, to test analogues for their tolerogenic potential. 
METHODS
Microassay for blastogenesis ANTIGEN PREPARATION Human peripheral blood was defibrinated on glass beads and centrifuged at 200 g for 30 min at room temperature. Packed erythrocytes (RBC) were removed for antigen preparation. The RBC were washed three times with 40 ml of Hanks' balanced salt solution (HBSS, Grand Island Biological Co., Grand Island, N. Y.), the buffy coat being discarded after each centrifugation. At the end of the procedure no leukocytes were visible in 0.2 ml of a waterlysed pellet. Urushiol is not water soluble. Therefore, all membrane antigen preparations were prepared in 10% dimethyl sulfoxide (DMSO) in HBSS. RBC (10'°cells) were resuspended in 4.5-ml aliquots of HBSS to which was added 0.5 ml of DMSO containing either urushiol (RBC-uru), or PDC (RBC-PDC), or neither (RBC-control). The amount of urushiol or PDC added ranged from 0.016 to 5.0 mg. After incubating for 30 min at room temperature, the cells were washed three times with 30 ml of sterile, distilled water and centrifuged at 20,000 g for 30 min at 4°C producing a colorless membrane pellet. Microscopically, these appeared as RBC ghosts similar to that described elsewhere (10) . Some membrane preparations called "DMSO washed" (described later) were subjected to three additional washes with 95% DMSO Lymphocyte antigen was prepared by defibrinating peripheral blood and separating the lymphocytes on a Ficoll (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) -Hypaque (Winthrop Laboratories, New York) gradient. Lymphocytes (107_ 108 cells) were resuspended in 9 ml RPMI 1640 to which 1 ml DMSO containing either 100 Ag catechol (Ly-uru) or no catechol (Ly-control) had been added. The suspension was incubated 30 min at 4°C and then washed twice in RPMI 1640 by centrifugation at 200 g and 4'C. The resultant antigen was an intact, viable lymphocyte that excluded trypan blue and could take up and retain a 51Cr label. The amount ofantigen added to each culture can either be expressed as membrane equivalents (ME) or micrograms urushiol per culture.
PREPARATION OF RESPONDER LYMPHOCYTES Total population. Peripheral blood was defibrinated, and lymphocytes were separated on Ficoll-Hypaque gradients. After washing twice in HBSS the lymphocytes were resuspended at the appropriate concentration in RPMI 1640 that contained 100 ,ug/ml streptomycin and 100 penicillin units/ml (Grand Island Biological Co.) and 20% autologous serum (RPMI-auto).
Rosette-rich and rosette-poor populations. Peripheral blood was drawn into a lipohepin (Riker Laboratories, Inc., Northridge, Calif.) -containing syringe, 50 U/ml final concentration, and the lymphocytes were separated on a FicollHypaque gradient. Rosette-rich lymphocyte populations were prepared as described by Littman (11) , with the exception that sheep RBC (Microbiological Media, Concord, Calif.) -absorbed fetal calf serum (Grand Island Biological Co.) was used in place of human AB positive serum. Additionally, the sheep RBC were lysed by a 5-s treatment with water rather than with ammonium chloride solution. The population remaining after the rosette-rich population was removed was designated rosette poor. The rosette-rich population constituted -60% of the total lymphocyte population and was composed primarily of small lymphocytes (6-8 microns in diameter) with a few polymorphonuclear leukocytes. No platelets, monocytes, or cellular debris could be detected. The populations were reacted with fluorescein-labeled goat anti-human immunoglobulin (Ig)G obtained unconjugated from Antibodies, Inc., Davis, Calif., conjugated by Dr. J. Riggs (California State Department of Health, Berkeley, Calif.), and used for staining lymphocytes as previously described (12) . No cellular staining was detected. The rosette-poor population made up the remaining 40% ofthe total population and consisted of rosette-negative lymphocytes, monocytes, and polymorphonuclear leukocytes. Virtually all these cells stained to some degree with fluorescein-labeled goat antihuman IgG.
Separation ofadherentfrom nonadherent cells. Adherent cells were prepared by a slight modification of a previously described method (13) . Peripheral blood lymphocytes were prepared as before, adjusted to 2 x 106 cells/ml in RPMIauto, and 20 ml was added to a sterile glass Erlenmeyer flask, 80-mm diameter bottom, and incubated 1 h at 37°C in 5% C02-95% air. The nonadherent cells were then decanted into a second flask which was again incubated under the same conditions, decanted, and resuspended in RPMI-auto at the appropriate concentrations. The adherent cells in the first flask were washed with 20 ml of warm RPMI-auto, then incubated 30 min at 37°C in 5% CO2 with 20 ml of RPMI-auto. The media was decanted, the flask washed twice with 10 ml of HBSS, 20 ml of phosphate-buffered saline was added, and the flask was refrigerated for 45 min, after which the cells were scraped off with a sterile rubber policeman. These cells were 85-90% viable. This yielded adherent cells representing =1% of the total population.
The esterase stains on cells in the depleted and glass-adherent cells were kindly performed by Professor J. Stobo (University of California, San Francisco) using previously described methods (14) (15) (16) Urushiol oil was either extracted from poison ivy or poison oak, and prepared as previously described (6) . The material used in this study was designated in that report (6) as the Mississippi lot. It is identified as either poison ivy or poison oak urushiol in that report (6) , and was confirmed by mass spectral analysis to consist primarily of the di-and triolefins of C-15 or C-17 side-chain compounds. Both poison oak and poison ivy urushiols contain C-15 and C-17 compounds, but the C-15 compounds make up >95% of poison ivy urushiol, and the C-17 compounds make up >98% of poison oak urushiols. Unless otherwise stated, poison oak urushiols were used throughout our studies. It was supplied as the oil or diluted in acetone at 100 mg/ml in 1.0-ml aliquots. It was dissolved in DMSO immediately before use and allowed to stand for 30 min at room temperature.
[3H]Hydrourushiol (-3 Ci/mM before dilution with PDC) was prepared by hydrogenation of the urushiol mixture with tritiated gas.
Crystalline PDC was kindly provided by Dr. William Acres of Letterman General Hospital, San Francisco, Calif. It was 2 Liberato, D., P. Jacob, and N. Castagnoli, Jr. Manuscript in preparation. stored at -70(C under nitrogen gas until use. Crystalline HDC was prepared according to the route described for [3H]HDC.
Catechol binding to membranes Solutions of [3H]PDC and [3H]
HDC of varying specific activity were used to prepare antigen from RBC or lymphocytes as described above. They were then treated in one of the following ways: (a) RBC membranes were washed three times with 30 ml of 95% DMSO and centrifuged at 20,000 g for 30 min. At each wash the supernatant fluid was counted, and after the final wash the membranes were solubilized in 0.5 ml of NCS solubilizer (Amersham Corp.) and counted.
(b) The membranes were precipitated in 20 ml of 1 N HC10.
The precipitate was centrifuged, and the pellet was resuspended in 0.5 N TCA in 95% ethanol. The precipitate was homogenized for 1 min using an Eberbach homogenizer (Eberbach Corp., Ann Arbor, Mich.), and the material was centrifuged 15 min at 200 g. The supernatant fluid was decanted and counted. This washing procedure was repeated 3-5 times until the radioactivity in the supernatant fluid was at background level. The precipitates were washed once with water, neutralized with 1 N NaOH, solubilized with NCS solubilizer, and counted.
Association of [3H]hydrourushiol with lymphocytes
To determine if alkylcatechols presented on RBC become associated with lymphocytes during in vitro culture, 0.5 ml of RBC-PDC was prepared as usual except that [3H]hydrourushiol, (1.6 x 109 dpm/mg sp act) was used instead of PDC. A mixture of 2 x 107 [3H]RBC-hydrourushiol ME and 2 x 106 lymphocytes in a total of 2 ml of RPMI-auto in Corning 16 x 125-mm sterile test tubes (Corning Glass Works, Scientific Products Div., Corning, N. Y.) was prepared and incubated from 0 to 120 h at 37°C in 5% C02-95% air. A separate tube that contained 0.5 ml of 6[3H]RBC-hydrourushiol was included as the control for the washing procedure. At various times triplicate tubes were removed and washed twice by centrifugation for 10 min at 200 g with 10 ml HBSS, followed by a third wash with 10 ml of phosphate buffered saline, pH 7.4. The pellet was resuspended in 1.0 ml of phosphate-buffered saline, and 0.1 ml was solubilized in NCS solubilizer and counted as described. Samples were corrected for quench.
Subjects
Subjects were healthy adults between 18 and 50 yr who were either nonimmune (nonreactive to 10 ,ug of urushiol by patch test), or immune (reactive to 2 ,ug of urushiol by patch test). Exposure was either accidental (spontaneous) or experimental (induced by applications of 10-20 ug ofurushiol on each arm).
RESULTS

Standard assay
All the catechols used in this study are very hydrophobic molecules but proved to be highly soluble in cell membranes and were not removed by aqueous washes (described later). RBC membranes or lymphocytes autologous to the responder lymphocytes pro-vided a convenient vehicle for adding the alkylcatechols to cultures. Varying numbers of membranes so prepared were added to cultured lymphocytes. Results from a typical microassay for cellular immunity to urushiol is depicted in Fig. 2 . Antigen-specific blastogenesis is seen on days 3, 4, and 5 after culture. The range of the optimal dose of antigen is rather narrow. With the standard RBC antigen preparation (0.5 mg of urushiol added to 1010 RBC in 5 ml) the optimal response was obtained with from 8 x 105 to 4 x 106 RBC-uru per culture well. Also compared in Fig. 2 is the response of a subject to HDC, PDC, and urushiol from either poison ivy or poison oak. Like the in vivo response of subjects exposed to either plant (8, 9) Doses of RBC-uru above 4 x 106 ME/well produced a diminished blastogenesis response. To determine whether this diminished blastogenic response was a result of a direct toxic effect of the antigen on the responder cells, a series of experiments using lymphocyte mitogens was carried out. These experiments tested the ability of responder lymphocyte populations, from either nonimmune individuals or those responsive in vitro to urushiol, to mount blastogenic reactions to PHA, Con A, and PWM in the presence of RBC-uru. The results of these experiments are shown in Table I . The response to the mitogens was lower than normal because the concentration of lymphocytes in the culture wells was selected to be optimal for urushiol responses rather than for mitogen responses.
The results of these experiments demonstrated that the response to the mitogen is not impaired, even with doses of RBC-uru up to 4 x 107 membrane equivalents. In fact, the response to these mitogens, even in the presence of a dose of RBC-uru that was completely inhibitory to the urushiol response, is unaltered or in some cases enhanced. Therefore, although the mechanism is unclear, the inhibition induced by higher doses of urushiol is not a function of direct toxicity to responder T cells.
Introduction of urushiol to sensitized lymphocytes
A series of experiments was carried out to investigate the urushiol specific blastogenic response when urushiol was added to cultures on various types of cells or membranes. Responder lymphocytes were shown to react with equal intensity and frequency to urushiol introduced into cultures on either autologous lymphocytes, autologous RBC membranes, or heterologous (sheep) RBC membranes. The results are depicted in Fig. 3 . In the first experiment (Fig. 3A) , the blastogenesis response to lymphocytes was comparable whether urushiol was added to cultures on autologous RBC or lymphocytes. Both the intensity of response and the dose of urushiol evoking maximal response were comparable with the two types of membrane preparations. Similarly, with a different donor it was demonstrated that both autolgous and heterologous RBC membranes could be used to introduce urushiol into cultures yielding responses of comparable intensity at comparable urushiol doses (Fig. 3B) . Similar results were obtained on four additional donors who were reactive to poison oak in vitro. Moreover, 10 individuals who were reactive in vivo but nonreactive in vitro when RBC-uru was used, were also nonreactive in vitro when Ly-uru was used. Therefore, both the intensity and the frequency of reactions were the same regardless of the membrane preparation. Table II , 80-90% of the total amount of HDC in the 5-ml vol was concentrated in 1010 RBC membranes. The HDC was firmly associated with the membranes since it was retained through cell lysis and several water washes and, as shown in Fig. 4 , there was an essentially linear uptake with doses of 1-5 mg
[3H]HDC/10'0 RBC membranes. This result is consistent with the hydrophobic character of the HDC. Most of the HDC could be removed by three subsequent DMSO washes leaving about 2% of original activity in the membranes (Fig. 4) . A more vigorous extraction was performed which involved protein precipitation with HC104 followed by several homogenizations of the precipitate in ethanolic TCA. This treatment solubilized:-99.9% ofthe activity. The remaining label corresponds to a maximum of 1.1 x 10-10 ,g (2 x 105 molecules) of catechol irreversibly bound per ME (Table II) .
Lymphocytes (Ly-uru). The maximal urushiol dose which could be added to 1 x 107 lvmphocytes in 5 ml HBSS-10% DMSO without causing agglutination was 0.05 mg. Amounts higher than 0.05 mg cause Ly-uru to separate as a gummy precipitate and the cells to adhere to the test tube walls. At 0.05 mg urushiol, the lymphocytes were 90% viable by trypan blue exclusion and 51Cr retention (through three HBSS washes). Experiments using [3H]HDC showed that a substantial amount of alkylcatechol was concentrated in lymphocyte cell membranes. As shown in Table II, 9.2% of the total 0.05 mg of added alkylcatechol was bound to the lymphocytes, which represents 4.6 x 10-7 ,tg/cell. As was observed with RBC membranes, the alkylcatechol, which remained membrane bound through several aqueous washes, was firmly associated with the lymphocyte membranes. Because the pelleted volume of the lymphocytes is <0.01 ml, 10% of the alkylcatechol in the reaction mixture that remained bound to the lymphocytes after three aqueous washes represented a substantial concentration. If no concentration were occurring one would expect 0.2% of the alkyl- 
Characterization of the responder cell population
The responder cell population was characterized by separating peripheral blood lymphocytes from a reactive donor total population (TP) into T-cellenriched, rosette-rich (RR) and T-cell-depleted, rosettepoor (RP) populations. Each population was tested for its ability to serve as a stimulator or as a responder in the urushiol-specific blastogenesis reaction. A concentration of 0.05 mg urushiol/107 lymphocytes, used to treat stimulator populations, rendered the Ly-uru nonresponsive to mitogen-induced blastogenesis (Table  IV) but maintained their viability (90% by trypan blue exclusion) and antigenicity. Table V depicts the results of such separation experiments. The urushiol responder cell was found in the RR population as can be seen by comparing the response of the RR and RP populations. The RP population produced a small response, probably a result of contamination with reactive T cells. Stimulator capacity resided in the RP population. This is evidenced by comparing the stimulatory ability of the various urushiol carriers: RBC and RR populations were inactive, whereas unseparated lymphocytes and the RP population were stimulatory. Although it appears in Table V that the TP-uru serves as a more efficient stimulator than the RP-uru population, this is probably explained by a shift in the dose of lymphocytes required for maximal stimulation. In fact, the RP-uru population produces a broad doseresponse curve characterized by near-maximal reactivity at stimulator lymphocyte concentrations lower than that required of TP-uru. The peak probably resides between 3.2 and 16 x 104 ME/well for the RP-uru stimulator population, whereas it is nearer 16 x 104 ME/well for TP-uru (Fig. 6) .
Characterization of the stimulator population
In an attempt to assess if the macrophage is the cell in the RP population that is responsible for stimulation, the lymphocytes from a responsive donor were de- (Table VII) .
All of the individuals who were nonimmne by in vivo testing were also nonreactive in vitro to urushiol. The immune subjects fell into two groups. The first group was reactive in vitro, with reactivity appearing -1-2 wk after contact with the oil and subsequent dermatitis. This reactivity lasted about 2 mo and then waned. Out of the 26 immune subjects, 15 were included in this group. The second group of 11 individuals was negative on in vitro testing at various times after the dermatitis. A few individuals showed inhibitory responses (blastogenesis is significantly less than background). The results obtained with this second group of individuals is exemplified by tests on two subjects (A. R. and V. B.).
DISCUSSION
Urushiol, the hapten that causes contact dermatitis to poison oak, ivy, and sumac, is composed of a family of hydrophobic alkylcatechols. The long aliphatic side chains of these catechols are responsible for the hydrophobic character of the urushiol oil which makes it perhaps the most lipophilic of the haptens that produce contact dermatitis. One consequence of this lipophilicity is a tendency for urushiol to concentrate in cell membranes. This has been verified by the finding that both RBC and lymphocyte membranes concentrated the alkylcatechols up to 100-fold. Furthermore, the catechols remained so firmly associated with the membranes that they were retained through a series of aqueous washes. However, in contrast to haptens such as trinitrophenyl in which almost all of the hapten associated with the membranes of lymphocytes is covalently bound (17, 18) , >98% of the catechol associated with RBC and lymphocyte membranes used to introduce antigen into the culture could be removed by DMSO washes. The relative lack of covalent bonding between urushiol and the cell membranes used for its introduction into the cultures makes the mechanism of antigen presentation unclear. Urushiol-induced contact dermatitis is thought to be a cellular immune reaction directed against the urushiol hapten. It has been suggested that a covalent bond is formed between the catechol ring of the alkylcatechols and a carrier molecule (19) . Thus, catechols might dissolve in the lipid membranes and undergo auto-oxidation to form electrophilic o-quinones that would alkylate reactive nucleophilic functionalities on biopolymers. This suggestion is supported by the finding that modification of the catechol ring in a manner that blocks its ability to form the quinone abolishes its reactivity in vivo (19) and in vitro (20) . Against this is our finding that the majority of the alkylcatechols in membranes are extractable by organic solvents. This indicates that the catechol moiety may be less reactive to auto-oxidation and covalent bond formation than has been previously proposed (6) .
If urushiol could be presented to the immune system as a noncovalently bound hapten that associated with membrane-bound proteins on lymphocytes because of its lipophilic character, one would expect that the reaction induced by urushiol-treated autologous lymphocytes would be markedly greater than that produced by urushiol-treated RBC. Alternatively, if urushiol irreversibly bound to RBC (by the criterion of being retained through organic solvent washes) was seen preferentially by the immune system, then the DMSO-washed RBC-uru should be a more efficient antigen. Neither of these alternatives occurred. In fact, the intensity of reaction was dependent solely upon the absolute amount of alkylcatechol introduced into the culture, and independent of the type of introducing membrane, or nature of the bond between urushiol and that membrane. Therefore, either urushiol is passed from the introducer membrane to another cell in the reactive population which, over the 5-d incubation period forms such a bond, or else urushiol may be utilized by the immune system noncovalently or covalently bound to either type of membrane.
We have shown that hydrourushiol presented to cultures on RBC membranes becomes increasingly associated with cultured lymphocytes over the 5-d incubation time. Also, although the blastogenically active cell is in the T-cell population, some cell in the RP population is required for activity, and this cell could be a macrophage. The re(quirement for a RP cell comes from experiments showing that RR (Tcell) populations of responder lymphocytes cannot be stimulated to blastogenesis by RBC-uru, but they respond very well to urushiol added on a RP population. The suggestion that the required cell is a macrophage comes from a separate set of experiments in which reactive lymphocyte populations were depleted of esterase-positive glass-adherent cells and the reactivity of the depleted population was decreased to _40% of normal. This activity was repleted by addition of the removed population, which contained 57% esterase-positive cells. The 40% residual reactivity remaining after depletion probably represented incomplete removal of macrophages (13) , but the ability to replete with a macrophage-enriched population suggests that this is a required cell type. All of these experiments indicate that the catechol ring is not spontaneously reactive. However, under culture conditions a covalent bond may be formed, and this may be an important function of the macrophage. Further studies are in progress to characterize the fate of urushiol in cultures.
In our population studies we found that lymphocytes from 58% of individuals tested after recent in vivo reaction to poison oak (from 2 wk to 3 mo) reacted in the antigen-specific in vitro blastogenesis assay. Lymphocytes from nonimmune (naive) and reactive individuals with no history of recent urushiol exposure did not respond in the in vitro assay. Lymphocytes from 42% of individuals with documented recent in vivo reactivity to urushiol were nonresponsive in vitro. There was internal consistency among individuals reacting either positive or negative in vitro, which confirms the validity of the assay. The number of false negatives in this test could indicate that suppressor cells may be a prominent feature in the human anti-urushiol cellular immune response. This was not noted in studies using hydrophilic moieties such as dinitrochlorobenzene in humans (21) but is consistent with findings in animals (22) (23) (24) . Alternatively, the ability to present urushiol in an immunogenic fashion in vitro may vary between individuals. This aspect of the urushiol reaction is also under investigation.
